Droperidol

Back to search

Molecule Structure

Scientific Name

Droperidol

Description of the Drug

Droperidol is a butyrophenone derivative and dopamine antagonist used to prevent and treat postoperative nausea and vomiting.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00450

Brand Name(s)

Dridol, Droleptan, Droperidol, Inapsine

Company Owner(s)

Watson Laboratories Inc, American Regent Inc, Igi Laboratories Inc, Abraxis Pharmaceutical Products, Solopak Laboratories Inc, Hospira Inc, Astrazeneca Lp, Luitpold Pharmaceuticals Inc, Akorn Operating Co Llc, Eurohealth International Sarl

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
D2-like dopamine receptor PROTEIN FAMILY ANTAGONIST CHEMBL2331075
Serotonin 2a (5-HT2a) receptor SINGLE PROTEIN ANTAGONIST CHEMBL224

Unichem Links

SureChEMBL SCHEMBL41426
PharmGKB PA449422
Human Metabolome Database HMDB0014593
WDI DROPERIDO
DrugBank DB00450
PubChem: Thomson Pharma 14780048
PubChem 3168
LINCS LSM-4193
Nikkaji J26.622A
PDBe USS
BindingDB 50017705
EPA CompTox Dashboard DTXSID6022973
DrugCentral 966
Brenda 217393
ChemicalBook CB9145418
Guide to Pharmacology 7172
GSRS 0d119967-5dac-418a-8bcb-6b2de6dfe87e
rxnorm DROPERIDOL
ChEBI 4717
NIH Clinical Collection SAM001247013
ZINC ZINC000019796080